Hydrochloric Acid

Hydrochloric Acid

SCHEMBL4807400

CC(N=Nc1n(C)c2ccccc2[n+]1C)=NN=c1ccn(C)cc1.[Cl-]

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.39
KDM4E B2RXH2 3/20 0.39
PKM P14618 2/20 0.39
MAPK1 P28482 2/20 0.39
KMT2A Q03164 2/20 0.39
RAB9A P51151 2/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
GAA P10253 1/20 0.36
RAD52 P43351 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ERAP1 Q9NZ08 1/20 0.34
ALDH1A1 P00352 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
LMNA P02545 3/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5198124 0.99 MAPT (0.39) MAPTKDM4EPKMMAPK1KMT2A
Hydrochloric Acid SCHEMBL4808159 0.85 MAPT (0.37) MAPTKDM4EPKMMAPK1KMT2A
Hydrochloric Acid SCHEMBL4799654 0.85 MAPT (0.35) MAPTKDM4EPKMMAPK1KMT2A
Hydrochloric Acid SCHEMBL4803998 0.85 MAPT (0.35) MAPTKDM4EPKMMAPK1KMT2A
SCHEMBL5199478 0.84 MAPT (0.37) MAPTKDM4EPKMMAPK1KMT2A
SCHEMBL5197336 0.84 MAPT (0.35) MAPTKDM4EPKMMAPK1KMT2A
SCHEMBL5196704 0.84 MAPT (0.35) MAPTKDM4EPKMMAPK1KMT2A
Hydrochloric Acid SCHEMBL4804279 0.83 KDM4E (0.38) MAPTKDM4EPKMMAPK1KMT2A
SCHEMBL5197825 0.81 KDM4E (0.39) MAPTKDM4EPKMMAPK1KMT2A
Hydrochloric Acid SCHEMBL4804952 0.78 MAPT (0.37) MAPTKDM4EPKMMAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7311736-B2 Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetra-azapentamethine compounds L'OREAL (FR) 2007-12-25 US claimed
EP-1548006-B1 Synthesis of tetraazapentamethine derivatives, keratin fibers dyeing process which uses such synthesis OREAL (FR) 2007-09-05 EP claimed
WO-2007071685-A1 COMPOSITION FOR DYEING KERATIN FIBRES WITH A TETRAAZAPENTAMETHINE CATIONIC DIRECT DYE AND ANOTHER PARTICULAR DIRECT DYE L'ORÉAL (FR) 2007-06-28 WO claimed
WO-2007071686-A1 COMPOSITION FOR DYEING KERATIN FIBRES WITH A TETRAAZAPENTAMETHINE CATIONIC DIRECT DYE, AN OXIDATION BASE AND A PARTICULAR COUPLER L'ORÉAL (FR) 2007-06-28 WO claimed
WO-2007071689-A1 COMPOSITION FOR DYEING KERATIN FIBRES WITH A TETRAAZAPENTAMETHINE CATIONIC DIRECT DYE AND ANOTHER PARTICULAR DIRECT DYE L'ORÉAL (FR) 2007-06-28 WO claimed
WO-2007071683-A1 COMPOSITION FOR DYEING KERATIN FIBRES WITH A TETRAAZAPENTAMETHINE CATIONIC DIRECT DYE AND A NONIONIC SURFACTANT L'ORÉAL (FR) 2007-06-28 WO claimed
WO-2007071688-A1 COMPOSITION FOR DYEING KERATIN FIBRES WITH A TETRAAZAPENTAMETHINE CATIONIC DIRECT DYE, A PARTICULAR OXIDATION BASE AND A COUPLER L'ORÉAL (FR) 2007-06-28 WO claimed
US-20050198744-A1 Applying 2-[5-(N-methyl-2-pyridinylidene)-1-formazano]-N-methylpyridinium chloride and an oxidizing agent, developing the desired coloration L'OREAL S.A. (FR) 2005-09-15 US claimed
US-20050028300-A1 Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetraazapentamethine compounds L'OREAL (FR) 2005-02-10 US claimed
US-7399320-B2 Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetra-azapentamethine compounds L'OREAL (FR) 2008-07-15 US disclosed
US-20080092307-A1 Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetra-azapentamethine compounds L'OREAL (FR) 2008-04-24 US disclosed
US-7311736-B2 Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetra-azapentamethine compounds L'OREAL (FR) 2007-12-25 US disclosed
US-7288120-B2 Synthesis of tetraazapentamethine compounds, and processes for dyeing keratin fibers using this synthesis L'OREAL S.A. (FR) 2007-10-30 US disclosed
WO-2007071689-A1 COMPOSITION FOR DYEING KERATIN FIBRES WITH A TETRAAZAPENTAMETHINE CATIONIC DIRECT DYE AND ANOTHER PARTICULAR DIRECT DYE L'ORÉAL (FR) 2007-06-28 WO disclosed
WO-2007071684-A2 COMPOSITION FOR DYEING KERATIN FIBRES WITH A TETRAAZAPENTAMETHINE CATIONIC DIRECT DYE AND AN AMINO SILICONE L'ORÉAL (FR) 2007-06-28 WO disclosed
WO-2007071683-A1 COMPOSITION FOR DYEING KERATIN FIBRES WITH A TETRAAZAPENTAMETHINE CATIONIC DIRECT DYE AND A NONIONIC SURFACTANT L'ORÉAL (FR) 2007-06-28 WO disclosed
WO-2007071686-A1 COMPOSITION FOR DYEING KERATIN FIBRES WITH A TETRAAZAPENTAMETHINE CATIONIC DIRECT DYE, AN OXIDATION BASE AND A PARTICULAR COUPLER L'ORÉAL (FR) 2007-06-28 WO disclosed
WO-2007071685-A1 COMPOSITION FOR DYEING KERATIN FIBRES WITH A TETRAAZAPENTAMETHINE CATIONIC DIRECT DYE AND ANOTHER PARTICULAR DIRECT DYE L'ORÉAL (FR) 2007-06-28 WO disclosed
US-20050198744-A1 Applying 2-[5-(N-methyl-2-pyridinylidene)-1-formazano]-N-methylpyridinium chloride and an oxidizing agent, developing the desired coloration L'OREAL S.A. (FR) 2005-09-15 US disclosed
US-20050028300-A1 Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetraazapentamethine compounds L'OREAL (FR) 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050028300-A1 Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetraazapentamethine compounds KRT18, TET1, DNMT1 MAPT 438/4885KDM4E 237/4885PKM 1082/4885
US-20050198744-A1 Applying 2-[5-(N-methyl-2-pyridinylidene)-1-formazano]-N-methylpyridinium chloride and an oxidizing agent, developing the desired coloration KRT18, TPM4, AZI2 MAPT 721/4885KDM4E 407/4885PKM 473/4885
US-20080092307-A1 Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetra-azapentamethine compounds KRT18, TUBA4A, TUBB4A MAPT 234/4885KDM4E 154/4885PKM 1327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.